Panic Disorder > Habituation-Based Exposure

Exposure Therapies for Anxiety Disorders

(OptEx Trial)

Recruiting in Palo Alto (17 mi)

Overseen By Michelle G Craske, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University of California, Los Angeles

No Placebo Group

Trial Summary

What is the purpose of this trial?

The study will compare the effects that two different approaches of exposure therapy have on reducing fear and anxiety in individuals with social anxiety disorder or panic disorder.

Eligibility Criteria

This trial is for adults aged 18-65 with social anxiety or panic disorder, who are either stable on current medications or not taking any. They must have access to telehealth and speak English. It's not for those with bipolar, psychosis, brain damage, recent substance abuse, serious medical conditions including pregnancy, concurrent anxiety therapy, or a history of suicidal behavior.

Inclusion Criteria

Zoom treatment sessions after March 2020 due to COVID-19.

I am between 18 and 65 years old.

Seeking treatment for social anxiety or panic disorder and demonstration of elevated scores using standardized self-report measures and diagnostic interview

Exclusion Criteria

I have not had thoughts of suicide or self-harm in the past year, nor attempted suicide in the last 10 years.

I have a serious health condition like heart, lung, nerve, or muscle disease, or I am pregnant.

You have abused or were dependent on drugs or alcohol within the last 6 months.

Participant Groups

The study compares two types of exposure therapy: Inhibitory Learning-Based Exposure and Habituation-Based Exposure. The goal is to see which method better reduces fear and anxiety in participants through remote treatment sessions.

Group I: Inhibitory Learning-Based Exposure Experimental Treatment 1 Intervention

Participants will receive exposure therapy aimed at increasing inhibitory learning.

Group II: Habituation-Based Exposure Active Control 1 Intervention

Participants will receive exposure therapy aimed at reducing fear responding.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

University of California, Los Angeles Los Angeles, CA

Who Is Running the Clinical Trial?

University of California, Los Angeles Lead Sponsor

References